Pfizer

Open: 36.5 Close: 36.65 Change: 0.15

You don't have read the whole internet to decide whether to invest in Pfizer Stock. Use an AI.

This document will help you to evaluate Pfizer without reading an infinite amount of sources. Relying only on stock quotes or prices to make investment decisions is a mistake. Analyzing and observing stock charts, highs and lows and other numerical data does not allow to evaluate the real value of a company. Stock quotes and prices are the result of underlying characteristics of a company and of events and news happening around them. For this reason, investing must be based on information, not numbers. As a solution, we programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Pfizer are: Pfizer, vaccine, COVID19, option, make, year, say, and the …

Concept Map

Semantic Network

Stock Summary

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products. Pfizer offers medicines and vaccines in various therapeutic areas. The company also provides biosimilars for chronic immune and inflammatory diseases.

Today's Summary

EU secures vaccine deals with Pfizer, and others for future pandemic. European Commission has secured deals with several European drugmakers to reserve capacity to make up to 325 million vaccines per year in case of a future global health emergency. Pfizer-BioNTech and Moderna vaccines ruled as only authorized COVID-19 boosters.

Today's News

European Commission has secured deals with Pfizer and several European drugmakers to reserve capacity to make up to 325 million vaccines per year in case of a future global health emergency. Pfizer said it understands the urgent need for better pandemic preparedness Pfizer Inc. invites public to view and Listen to Webcast of Pfizer Discussion at Healthcare Conference. Pfizer announces positive Marstacimab results from Pivotal Phase 3 Hemophilia A and B trial. Pfizers PAXLOVID™ Receives FDA Approval for Adult Patients at High Risk of Progression to Severe COVID-19. Pfizer Inc. (Pfe) latest stock news & headlines - Yahoo Finance (PFE) Latest Stock News & Headlines - Yahoo Mail Summary Company Insights Statistics Historical Data Profile Financials Analysis Options Holders. EU secures vaccine deals with Pfizer, and others for future pandemic. Ex-Pfizer employee charged with using inside information about Covid-19 treatment Paxlovid to make illegal options trades. Pfizer and GSK agree to make up to 325 million vaccines per year. Pfizer-BioNTech and Moderna vaccines ruled as the only authorized COVID-19 boosters. Pfizer bivalent original/Omicron BA.1.1 18 years formulation. Moderna bivalent omicron B.4 and BA.5 subvariants target original SARS-CoV-2 virus. Pfizer-BioNTech COVID-19 vaccine was granted emergency use authorization (EUA) by the U.S. Pfizer says COVID vaccine will cost $110-$130 per dose when US stops paying. Pfizer expects that people with private health insurance or coverage through public programs like Medicare or Medicaid will pay nothing. Latest COVID booster shots will be released before human testing is complete. Pfizer (nyse:pfe) - benzinga. looking at pfizers recent unusual options activity - pfizer. Benzinga s options scanner spotted 10 uncommon options trades for Pfizer. Pfizer biosimilars 12 June 2023 14:29 Latest White Papers. Pfizers COVID-19 vaccines have been approved by the Food and Drug Administration. Pfizer said it plans to charge $110 to $130 for a dose of its vaccine in the United States in October 2022. Pfizer plans to sell its covid vaccine at a 10,000% markup in 2023. Pfizer will charge as much as $130 for Comirnaty, which costs an estimated $1.18 per dose to produce.

Stock Profile

"Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic, migraine, and women's health under the Eliquis, Nurtec ODT/Vydura, and the Premarin family brands; infectious diseases with unmet medical needs under the Prevnar family, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and COVID-19 prevention and treatment, and potential future mRNA and antiviral products under the Comirnaty and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; amyloidosis, hemophilia, endocrine diseases, and sickle cell disease under the Vyndaqel family, Oxbryta, BeneFIX, and Genotropin brands; sterile injectable and anti-infective medicines under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, and Panzyga brands; and biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Inlyta, Retacrit, Lorbrena, and Braftovi brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, individual provider offices, retail pharmacies, and integrated delivery systems, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York."

Keywords

The game is changing. There is a new strategy to evaluate Pfizer fundamental value, possible risks and most salient advantages. Investors have traditionally relied in reading large amounts of text to evaluate the fundamental value of a stock or company. However, the development of Artificial Intelligence (AI) tools is modifying the way investments are evaluated in markets. Today, machine learning, natural language processing and bigdata allow making this process automatic, reducing large amounts of text to the elements that have a higher activation in a neural network. We programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Pfizer are: Pfizer, vaccine, COVID19, option, make, year, say, and the most common words in the summary are: pfizer, vaccine, covid19, best, subscribe, news, see, . One of the sentences in the summary was: Pfizer-BioNTech and Moderna vaccines ruled as only authorized COVID-19 boosters.. Other searches related to this term that the AI found were: stockmarketlive, livestock, stockmarketforbeginners, thestockmarket, stockmarkettoday, stockmarkettrading, stockmarketstocks, todaystockmarket, thestockmarket, marketnews, stockmarketnews, whatisstockmarket, usstockmarket, stockmarketopen. #pfizer #vaccine #covid19 #best #subscribe #news #see.